Tactile Systems Technology, Inc. Reports Preliminary Revenue Results for the Full Year and Fourth Quarter Ended December 31, 2017
January 08, 2018 at 11:45 am
Share
Tactile Systems Technology, Inc. reported preliminary revenue results for the full year and fourth quarter ended December 31, 2017. For the full year, revenue is expected to be in the range of $108.5 million to $109.0 million, representing growth revenue is expected to be comprised of:
For the fourth quarter, total revenue is expected to be in the range of $34.1 million to $34.6 million, representing growth of approximately 28% to 29% year-over-year.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
TACTILE SYSTEMS TECHNOLOGY, INC. 
